The healthcare sector is facing many US Food and Drug Administration (FDA) hurdles. This is only a temporary turmoil, he says. The big Pharma names from India have huge opportunities in the US as the demand for generic drugs from India steadily rises.
In the last nine months, the government has taken many right steps to improve the economy, says Shiv Puri, founder and MD of TVF Capital Advisors. It now needs to focus especially on the infrastructure sector in the Budget, he adds.